Provided by Tiger Fintech (Singapore) Pte. Ltd.

Repligen

141.51
+4.313.14%
Post-market: 141.510.00000.00%16:32 EDT
Volume:581.93K
Turnover:82.02M
Market Cap:7.95B
PE:-337.81
High:142.66
Open:140.36
Low:138.32
Close:137.20
Loading ...

Repligen (RGEN) Q1 Earnings: What To Expect

StockStory
·
28 Apr

Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY), Ironwood Pharma (IRWD) and Repligen (RGEN)

TIPRANKS
·
25 Apr

Will Repligen (RGEN) Beat Estimates Again in Its Next Earnings Report?

Zacks
·
24 Apr

Repligen (RGEN) Reports Next Week: Wall Street Expects Earnings Growth

Zacks
·
22 Apr

Three Stocks That May Be Undervalued In April 2025

Simply Wall St.
·
17 Apr

Repligen Corp : Leerink Partners Cuts Target Price to $180 From $200

THOMSON REUTERS
·
17 Apr

Repligen Corp : Canaccord Genuity Cuts Target Price to $150 From $170

THOMSON REUTERS
·
17 Apr

Repligen Is Maintained at Hold by Canaccord Genuity

Dow Jones
·
17 Apr

Repligen price target lowered to $150 from $170 at Canaccord

TIPRANKS
·
17 Apr

Repligen to Report First Quarter 2025 Financial Results

GlobeNewswire
·
15 Apr

Repligen (RGEN) Gets a Hold from Guggenheim

TIPRANKS
·
09 Apr

Repligen Appoints Jacob Johnson as Vice President Investor Relations

THOMSON REUTERS
·
08 Apr

Press Release: Repligen Appoints Jacob Johnson As Vice President Investor Relations

Dow Jones
·
08 Apr

RBC Cuts Price Target on Repligen to $202 From $219, Keeps Outperform Rating

MT Newswires Live
·
08 Apr

Repligen (RGEN) Moves 3.7% Higher: Will This Strength Last?

Zacks
·
08 Apr

Repligen Director Makes a Multi-Million Dollar Stock Move!

TIPRANKS
·
20 Mar

Evercore ISI Initiates Repligen at In Line With $155 Price Target

MT Newswires Live
·
18 Mar

Repligen initiated with an In Line at Evercore ISI

TIPRANKS
·
18 Mar

Q4 Rundown: PacBio (NASDAQ:PACB) Vs Other Life Sciences Tools & Services Stocks

StockStory
·
17 Mar

A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack

StockStory
·
11 Mar